Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Intraoperative Hypotension in Major Noncardiac Surgery
NCT05436522Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Aug 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in intraoperative hypotension (IOH) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Time-weighted average intraoperative mean arterial pressure under 65 mmHg. Started Aug 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
intraoperative hypotension (IOH)
Beyond the preview
Go deeper on NCT05436522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05436522.